Established 1999
 
8,000 companies from
USA,Canada and India.
 
   
Search over 25,000 News & Earnings Archives    
 
Market Update : 
Lackluster Averages Despite Job Data
Author: 123jump.com Staff
123jump.com
Last Update: 4:12 PM EST March 09 2007


(Continued)

Email article | Print article

Trading in New York remained volatile in the face of weekly jobless and monthly trade deficit data. At the end of the previous week 95,000 jobs were added and Commerce Department said the January U.S. trade deficit narrowed by 3.8% to $59.12 billion. Fed Governor Beis cautioned on sub-prime loans. New Century Financial shares fell 12%. Yahoo dropped 5% but Big Lots gained 19%. Crude-oil prices declined $1.36 or 2.66% to $60.23 a barrel.

 
Hindustan Lever was down 0.14% to Rs 183.55, after rallying close to 10% on significant volume on Thursday. Cigarette large-cap ITC was down 3.44% to Rs 154.35.

Index heavy Reliance Industries shed 2% to Rs 1,308.05. Reliance Communications lost 2.5% to Rs 423, L&T declined 2.5% to Rs 1,482 and Dr Reddey’s dropped to Rs 660.


6:30AM Europe was lower Friday on weak metal, drug and mining sectors.
European markets were off to a weak start on Friday. By mid morning, Frankfurt Xetra Dax fell 0.5% to 6,677.11, the CAC 40 in Paris shed 0.8% to 5,482.19 and London FTSE 100 lost 0.4% to 6,203.8.

Advancers

Thales, the French defence electronics group, topped the earnings table after posting a better-than-expected 4.5% increase in full-year operating profit, while guiding strong revenue growth for the next two years. Thales shares added 4.1%. Sanofi-Aventis advanced 0.1% after Goldman upgraded it to buy, saying concerns over Plavix and Lovenox are now priced in. Ahold, the Dutch retailer, was up 1.6% as bids circulated in for the company US Foodservice division, valued at around $6 billion.

Decliners

EADS, the European aerospace group, fell 1.8% after losses at its Airbus unit were largely responsible for an 86% drop in 2006 operating profits. The pharmaceuticals sector was led lower after Goldman Sachs lowered its rating on the UK GlaxoSmithKline from neutral to sell. GlaxoSmithKline dropped 1.7%. Meanwhile Novartis, the Swiss drugmaker, fell 2.1% as investors took profits on its recent strong performance.
  1  2  3  4 More: Market Update Archive

 


 

350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries

© 1999-2008 123jump.com. All rights reserved